EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection

Xue Liu, Laurye Van Maele, Laura Matarazzo, Daphnée Soulard, Vinicius Alves Duarte da Silva, Vincent de Bakker, Julien Dénéréaz, Florian P Bock, Michael Taschner, Jinzhao Ou, Stephan Gruber, Victor Nizet und 2 weitere

Cell Host & Microbe · 2024

DOI: 10.1016/j.chom.2024.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024. Verfasst von Xue Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, Base for International Science and Technology Cooperation, Carson Cancer Stem Cell Vaccines R&D Center, International…. Hauptthemen laut MEDLINE: Pneumococcal Infections, Influenza, Human, Superinfection, Influenza Vaccines. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several vaccines targeting bacterial pathogens show reduced efficacy upon concurrent viral infection, indicating that a new vaccinology approach is required. To identify antigens for the human pathogen Streptococcus pneumoniae that are effective following influenza infection, we performed CRISPRi-seq in a murine model of superinfection and identified the conserved lafB gene as crucial for virulence. We show that LafB is a membrane-associated, intracellular protein that catalyzes the formation of galactosyl-glucosyl-diacylglycerol, a glycolipid important for cell wall homeostasis. Respiratory vaccination with recombinant LafB, in contrast to subcutaneous vaccination, was highly protective against S. pneumoniae serotypes 2, 15A, and 24F in a murine model. In contrast to standard capsule-based vaccines, protection did not require LafB-specific antibodies but was dependent on airway CD4+ T helper 17 cells. Healthy human individuals can elicit LafB-specific immune responses, indicating LafB antigenicity in humans. Collectively, these findings present a universal pneumococcal vaccine antigen that remains effective following influenza infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal InfectionsInfluenza, HumanSuperinfectionInfluenza VaccinesHumansAnimalsMiceStreptococcus pneumoniaeSerogroupTh17 CellsDisease Models, AnimalPneumococcal VaccinesAntigens, BacterialAntibodies, Bacterial

Stichwörter der Autor:innen

CRISPRi-seqTh17genome-wide vaccinologyintranasal vaccinenon-vaccine serotypespneumococcusprotein antigensuperinfectiontissue-resident memory T lymphocytesvaccine discovery

Substanzen

Pneumococcal VaccinesAntigens, BacterialInfluenza VaccinesAntibodies, Bacterial

Autor:innen und Institutionen

  • Department of Pathogen Biology, Base for International Science and Technology Cooperation, Carson Cancer Stem Cell Vaccines R&D Center, International Cancer Center, Shenzhen University Medical School, Shenzhen 518060, C…
  • University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, 59000 Lille, France.
  • Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland.
  • Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.
  • University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, 59000 Lille, France. Electronic address: jean-claude.sirard@inserm.fr.
  • Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Biophore Building, CH-1015 Lausanne, Switzerland; Department of Pediatrics, University of California, San Diego, La Jolla,…

Förderung

  • ERC
  • Swiss National Science Foundation

Zitieren

APA

Liu, X., Van Maele, L., Matarazzo, L., Soulard, D., Alves Duarte da Silva, V., de Bakker, V., Dénéréaz, J., Bock, F. P., Taschner, M., Ou, J., Gruber, S., Nizet, V., Sirard, J. C., & Veening, J. W. (2024). A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.02.002

Vancouver

Liu X, Van Maele L, Matarazzo L, Soulard D, Alves Duarte da Silva V, de Bakker V, et al. A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection. Cell Host & Microbe. 2024. doi:10.1016/j.chom.2024.02.002

BibTeX
@article{Liu2024,
  author = {Liu, Xue and Van Maele, Laurye and Matarazzo, Laura and Soulard, Daphnée and Alves Duarte da Silva, Vinicius and de Bakker, Vincent and Dénéréaz, Julien and Bock, Florian P and Taschner, Michael and Ou, Jinzhao and Gruber, Stephan and Nizet, Victor and Sirard, Jean-Claude and Veening, Jan-Willem},
  title = {A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection},
  journal = {Cell Host & Microbe},
  year = {2024},
  doi = {10.1016/j.chom.2024.02.002}
}
Kostenlos starten →